News Sentiment

BGLC sentiment intelligence

BioNexus Gene Lab Corp Common stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 51 Balanced news tone 58 relevant articles
Exchange NASDAQ United States
Sector Basic Materials Market context
Industry Specialty Chemicals Read-through group
Latest close 1.81 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-10.8% over one week, -15.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Brenntag stock holds steady as the chemicals distributor focuses on earnings and portfolio strategy

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -10.8% Price reacting lower
Trend fit Trend inactive -15.4% over four weeks
Fair value -65.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 37
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Ad Hoc News 9
TradingView 7
TradingKey 6
Market source 4
Stock Titan 4
dars.gov.et 4
DonanımHaber 3
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 13
Guidance 5
Macro sensitivity 3
Deals and strategy 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58
Sahm Direct company coverage

12 Industrials Stocks Moving In Wednesday's After-Market Session

This article lists 12 industrial stocks that experienced significant movement in Wednesday's after-market session, categorizing them as gainers and losers. Companies like Linkers Industries and Heico saw increases due to factors such as earnings reports, while BioNexus Gene Lab a

Tone
Negative 29/100
Event
Earnings
Published
27 May 2026 19:40
Source
Sahm
TradingView Direct company coverage

BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) — 10-Q Summary

BioNexus Gene Lab Corp (BGLC) reported its first-quarter 2026 results, showing a significant decline in revenue to $22.84K, a 98.9% decrease year-over-year, while reducing its net loss per share to ($0.23), a 35.2% improvement. The company is actively pivoting its business strate

Tone
Negative 36/100
Event
Earnings
Published
15 May 2026 21:10
Source
TradingView
TradingKey Direct company coverage

BioNexus Gene Lab Corp BGLC

This page provides an overview of BioNexus Gene Lab Corp (BGLC) stock performance, showing a closing price of $2.015, a decrease of 2.18%. It includes current market data, a market capitalization of $4.87M, and sections for financials, discussions, and analysis. The platform also

Tone
Negative 41/100
Event
Market update
Published
12 May 2026 19:09
Source
TradingKey
Simply Wall Street Direct company coverage

BioNexus Gene Lab (Nasdaq:BGLC) - Stock Analysis

BioNexus Gene Lab (Nasdaq:BGLC) is analyzed with a market cap of US$5.2m. The company's stock has shown significant declines over multiple periods, including a 99.07% drop over five years, and analysts are not currently covering it. There are substantial risks highlighted, such a

Tone
Negative 8/100
Event
Market update
Published
27 Apr 2026 06:38
Source
Simply Wall Street
TradingView — Track All Markets Direct company coverage

BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61)

BioNexus Gene Lab reported fiscal-year revenue of $7.42 million, a 21.9% decline due to lower Chemrex volume and foreign exchange. The company also posted a net loss per share of $(1.607) and an 88% increase in operating loss year-over-year. Despite the revenue decline, gross mar

Tone
Negative 18/100
Event
Earnings
Published
14 Apr 2026 21:39
Source
TradingView — Track All Markets
ChartMill Direct company coverage

BGLC Stock Price, Quote & Chart | BIONEXUS GENE LAB CORP (NASDAQ:BGLC)

BIONEXUS GENE LAB CORP (NASDAQ:BGLC) is currently trading at $2.18, down 3.08% today, and has seen significant declines over longer periods. ChartMill gives BGLC a technical rating of 0/10 and a fundamental rating of 3/10, citing poor profitability but good financial health. The

Tone
Negative 39/100
Event
Analyst action
Published
04 Apr 2026 11:09
Source
ChartMill
Stock Titan Direct company coverage

BioNexus Gene Lab (NASDAQ: BGLC) taps new CCO to drive Fidelion VitaGuard MRD commercialization

BioNexus Gene Lab (NASDAQ: BGLC) announced the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of its affiliate, Fidelion Diagnostics. Dr. Meyyappan will lead Fidelion's global commercial strategy and partnerships for the VitaGuard™ minimal residual disease liquid

Tone
Positive 65/100
Event
Market update
Published
17 Mar 2026 18:39
Source
Stock Titan
ARC Group Direct company coverage

About BioNexus Gene Lab Corp.

Tone
Neutral 50/100
Event
Market update
Published
02 Dec 2025 08:00
Source
ARC Group